Genetic Testing Study Approved in Senate FDA Bill June 11, 2007
Neither of two genetic testing oversight bills got on the fast track as the Senate took up legislation reauthorizing Food & Drug Administration user fees for drug and device makers. But the final measure the Senate passed by a vote of 93 to 1 (S. 1082) included an amendment calling for an Institute of Medicine study to assess the safety and quality of genetic testing and to make recommendations to improve federal oversight and regulation of such tests.